AstraZeneca Statistics and Revenue Totals for 2024
Last Updated on: January 14th, 2024
Here are a few of the most interesting AstraZeneca statistics and facts I was able to dig up including restaurant count, revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
AstraZeneca Facts
Here is pretty much everything you ever wanted to know about AstraZeneca.
- Website: Official Website
- Year Founded: 1913
- Headquarters: Cambridge, England
- Current Chief Executive: Pascal Soriot
- Subsidiaries / Brands: Sybicort, Tagrisso, Nexium, Crestor, Farxiga, Brilinta, Pulmicort, Faslodex and Zoladex
AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered in Cambridge, England. Established in 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the United Kingdom, AstraZeneca has since become a major player in the global healthcare and pharmaceutical industry.
AstraZeneca specializes in the research, development, and commercialization of innovative pharmaceuticals, with a particular focus on areas such as oncology, cardiovascular, respiratory, and immunology. The company is known for its commitment to addressing unmet medical needs and improving patient outcomes.AstraZeneca has a diverse portfolio of prescription medicines, including blockbuster drugs like Crestor, Nexium, and Symbicort. The company has also been at the forefront of vaccine development, collaborating with academic institutions and organizations to develop vaccines for various diseases, including COVID-19. Their COVID-19 vaccine, developed in partnership with the University of Oxford, has played a significant role in global vaccination efforts.In addition to its pharmaceuticals and vaccines, AstraZeneca is actively involved in research and development in areas such as personalized medicine, genomics, and biotechnology.
AstraZeneca Statistics
AstraZeneca Revenue Totals
AstraZeneca annual revenue:
- 2022: $44.35 billion
- 2021: $36.5 billion
- 2020: $25.89 billion
- 2019: $24.384 billion
- 2018: $22.1 billion
- 2017: $22.5 billion
- 2016: $23 billion
- 2015: $24.7 billion
Additional AstraZeneca Statistics
AstraZeneca largest therapeutic area (based on sales):
Cardiovascular & Metabolic Diseases (36%)
AstraZeneca largest geographical region (based on sales):US (31%)
Please note that some of these numbers are easier to find than others. A few of these AstraZeneca statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
